Skip to main content
All lobbying filings

UCB, Inc.

UCB, Inc. filed a Q2 report for UCB, Inc. on July 17, 2026.

Lobbying for UCB, Inc.

As filed: UCB, INC. for UCB, INC.

All filings by UCB, Inc. · Everything UCB, Inc. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Expenses
$710,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Pharmacy

H.R. 5509/S. 2903 - Safe Step Act H.R. 6423/S. 864 - HELP Copays Act H.R. 1189/S. 494 - National Plan for Epilepsy Act Drug Pricing

Trade (domestic/foreign)

Tariffs

 Bills named in this filing 6

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem